Evidence map›Paper›PMID 30677240›Full record

SynthesisThoracic cancer2019

Efficacy of radiofrequency ablation and microwave ablation in the treatment of thoracic cancer: A systematic review and meta-analysis.

Yuan-Dong Sun, Hao Zhang, Jing-Zhou Liu, Hui-Rong Xu, Hui-Yong Wu, Hui-Zhuan Zhai, Chang-Yan Lu, Xia Zhao, Ye-Qiang Chen, Lin-Lin Zhou and 1 more

Open access · goldAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Thoracic cancer, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Yuan-Dong SunSchool of Medicine and Life Sciences, Affiliated to University of Ji'nan-Shandong Academy of Medical Sciences, Jinan, China.
Hao ZhangSchool of Medicine and Life Sciences, Affiliated to University of Ji'nan-Shandong Academy of Medical Sciences, Jinan, China.
Jing-Zhou LiuShandong Tumor Hospital Affiliated to Shandong University, Jinan, China.
Hui-Rong XuInvasive Technology Department, Shandong Tumor Hospital Affiliated to Shandong University, Jinan, China.
Hui-Yong WuShandong Tumor Hospital Affiliated to Shandong University, Jinan, China.
Hui-Zhuan ZhaiShandong Tumor Hospital Affiliated to Shandong University, Jinan, China.
Chang-Yan LuSchool of Medicine and Life Sciences, Affiliated to University of Ji'nan-Shandong Academy of Medical Sciences, Jinan, China.
Xia ZhaoSchool of Medicine and Life Sciences, Affiliated to University of Ji'nan-Shandong Academy of Medical Sciences, Jinan, China.
Ye-Qiang ChenSchool of Medicine and Life Sciences, Affiliated to University of Ji'nan-Shandong Academy of Medical Sciences, Jinan, China.
Lin-Lin ZhouSchool of Medicine and Life Sciences, Affiliated to University of Ji'nan-Shandong Academy of Medical Sciences, Jinan, China.
Jian-Jun HanInvasive Technology Department, Shandong Tumor Hospital Affiliated to Shandong University, Jinan, China.ORCID 0000-0001-9675-3354
University of Jinan · CNShandong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRadiofrequency ablation and microwave ablation are frequently prescribed for thoracic cancer. However, few writers have been able to draw on any systematic research into the differences between the two ablation methods.

methodsA literature search was carried out using Embase, PUBMED, Web of Science, Cochrane Library, and CNKI databases, with additional searches carried out manually using terms associated with thoracic cancer and thermal ablation. Then we used Google Scholar for a complementary search. Data were extracted from studies of patients that underwent radiofrequency ablation or microwave ablation, and the investigator carried out efficacy evaluation and follow up. The data obtained from the literature were summarized and analyzed using Cochrane Revman software Version 5.3 and SPSS 22.0.

resultsThere were seven comparative studies, but no randomized studies identified for data extraction; 246 patients received radiofrequency ablation therapy and 319 controls received microwave ablation. There was no significant difference in the six-month, one-year, two-year, and three-year survival rates, and adverse reactions were found in the two treatments. For patients' long-term survival rate, the two treatments can achieve a similar survival time.

conclusionIn the treatment of thoracic cancer, microwave ablation can achieve the same efficacy as radiofrequency ablation.

Indexed as

MicrowavesRadiofrequency AblationThoracic NeoplasmsHumansSurvival RateTreatment OutcomeMicrowave ablationoverall survivalpulmonary tumorradiofrequency ablationthoracic cancer

Identifiers

PMID30677240
PMCPMC6397911
OpenAlexW2911876873

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.